Association of MYO9B gene polymorphisms with inflammatory bowel disease in Chinese Han population

Table 3 Allele and genotype frequencies of the MYO9B SNPs rs1545620 in IBD patients vs controls, n (%)

	Controls (n = 402)	IBD (n = 442)			CD (n = 207)			UC (n = 235)
			OR (95%CI)	Pcorr		OR (95%CI)	Pcorr		OR (95%CI)	Pcorr
GF
AA	42 (10.4)	63 (14.3)	1.47 (0.56-3.85)	0.43	26 (12.6)	2.01 (0.71-5.66)	0.21	37 (15.7)	1.26 (0.31-3.25)	0.61
AC	135 (33.6)	128 (28.9)	0.86 (0.62-1.94)	0.29	63 (30.4)	0.91 (0.27-2.49)	0.07	65 (27.7)	0.82 (0.57-2.61)	0.37
CC	225 (56.0)	251 (56.8)	1.03 (0.37-2.19)	0.71	118 (57.0)	1.35 (0.33-2.19)	0.57	133 (56.6)	1.14 (0.61-3.77)	0.84
AF
A	219 (27.2)	254 (25.9)	0.96 (0.44-2.91)	0.61	115 (27.8)	1.09 (0.39-2.46)	0.37	139 (29.6)	1.16 (0.57-3.14)	0.57
C	585 (72.8)	727 (74.1)	1.07 (0.56-2.28)	0.77	299 (72.2)	0.92 (0.49-3.17)	0.42	331 (70.4)	0.92 (0.77-2.51)	0.39

IBD: Inflammatory bowel disease; GF: Genotype frequencies; AF: Allele frequencies; CD: Crohn’s disease. Genotype and allele frequencies in patients and controls were compared using the χ² test; P_corr: Corrected P value.